Cargando…

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease

Having a parent affected by late-onset Alzheimer’s disease (AD) is a major risk factor for cognitively normal (NL) individuals. This study explores the potential of PET with (18)F-FDG and the amyloid- β (Aβ) tracer (11)C-Pittsburgh Compound B (PiB) for detection of individual risk in NL adults with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, John, Tsui, Wai H., Li, Yi, McHugh, Pauline, Williams, Schantel, Cummings, Megan, Pirraglia, Elizabeth, Solnes, Lilja, Osorio, Ricardo, Glodzik, Lidia, Vallabhajosula, Shankar, Drzezga, Alexander, Minoshima, Satoshi, de Leon, Mony J., Mosconi, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270202/ https://www.ncbi.nlm.nih.gov/pubmed/25530915 http://dx.doi.org/10.4236/ami.2014.42003

Ejemplares similares

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study
por: Mosconi, Lisa, et al.
Publicado: (2014)

Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects
por: Glodzik, Lidia, et al.
Publicado: (2016)

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study
por: Matthews, Dawn C., et al.
Publicado: (2014)

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity
por: Doherty, Leana, et al.
Publicado: (2017)

Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2018)

Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders
por: Wang, Yujie, et al.
Publicado: (2021)

Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery
por: Mosconi, Lisa, et al.
Publicado: (2017)

Lower mortality risk in APOE4 carriers with normal cognitive ageing
por: Pirraglia, Elizabeth, et al.
Publicado: (2023)

Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
por: Sadaghiani, Mohammad S., et al.
Publicado: (2023)

Decreased occipital lobe metabolism by FDG-PET/CT: An anti–NMDA receptor encephalitis biomarker
por: Probasco, John C., et al.
Publicado: (2017)

Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
por: Probasco, John C., et al.
Publicado: (2017)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area
por: Walters, Michelle J, et al.
Publicado: (2018)

Dialysis Related Amyloid Arthropathy on (18)FDG PET-CT
por: Kecler-Pietrzyk, A, et al.
Publicado: (2014)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Automated lesion detection of breast cancer in [(18)F] FDG PET/CT using a novel AI-Based workflow
por: Leal, Jeffrey P., et al.
Publicado: (2022)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
por: Daniela, Perani, et al.
Publicado: (2014)

Statistical Parametric Mapping in Amyloid Positron Emission Tomography
por: Smith, Natasha M., et al.
Publicado: (2022)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)

Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study
por: Mosconi, Lisa, et al.
Publicado: (2018)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”
por: Perani, Daniela, et al.
Publicado: (2014)

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
por: Ikari, Yasuhiko, et al.
Publicado: (2016)

Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
por: Iaccarino, Leonardo, et al.
Publicado: (2019)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019)

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
por: Walker, Zuzana, et al.
Publicado: (2018)

Assessment of Tau Tangles and Amyloid-β Plaques Among Super Agers Using PET Imaging
por: Hoenig, Merle C., et al.
Publicado: (2020)

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats
por: Rohleder, Cathrin, et al.
Publicado: (2016)

Visualization of Dialysis-Related Amyloid Arthropathy on (18)F-FDG PET-CT Scan
por: Cheon, Miju, et al.
Publicado: (2022)

Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area
por: Mosconi, Lisa, et al.
Publicado: (2018)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

Obesity and Race May Explain Differential Burden of White Matter Hyperintensity Load
por: Seixas, Azizi A, et al.
Publicado: (2021)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
por: Bouwman, Femke, et al.
Publicado: (2018)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Regional uptakes from early-frame amyloid PET and (18)F-FDG PET scans are comparable independent of disease state
por: Myoraku, Alison, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqu9ql6sbobhf5pl1qs6i00buo